欧盟GMP附录11-计算机系统(中英文对照).pdf
《欧盟GMP附录11-计算机系统(中英文对照).pdf》由会员分享,可在线阅读,更多相关《欧盟GMP附录11-计算机系统(中英文对照).pdf(8页珍藏版)》请在三一文库上搜索。
1、. . EUROPEAN COMMISSION 欧盟委员会 HEALTH AND CONSUMERS DIRECTORATE-GENERAL 卫生与消费者协会 Public Health and Risk Assessment 公共卫生与风险评估 Pharmaceuticals 药品 Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products in the European Union 欧盟药品生产规范 Volume 4 卷4 Good Manufacturing Prac
2、tice Medicinal Products for Human and Veterinary Use 人用与兽用药品良好生产管理规范 Annex 11: Computerised Systems 附件11:计算机系统 Legal basis for publishing the detailed guidelines: Article 47 of Directive 2001/83/EC on the Community code relating to medicinal products for human use and Article 51 of Directive 2001/82
3、/EC on the Community code relating to veterinary medicinal products. This document provides guidance for the interpretation of the principles and guidelines of good manufacturing practice (GMP) for medicinal products as laid down in Directive 2003/94/EC for medicinal products for human use and Direc
4、tive 91/412/EEC for veterinary use. 依法发布的具体指导方针: 2001/83/EC第47条人用药品规范和 2001/82/EC第51条 兽用药品规范。此文件为2003/94/EC人用药品和 91/412/EEC兽用药品 GMP法规、 指导方针的解释提供了指导。 Status of the document: revision 1 文件版本:修订本 1 Reasons for changes: the Annex has been revised in response to the increased use of computerised systems
5、and the increased complexity of these systems. Consequential amendments are also proposed for Chapter 4 of the GMP Guide. 修订原因:为增强计算机系统的功能和复杂性而修订此附件。相应修正案也已被 提议作为 GMP指南的第 4章。 Deadline for coming into operation: 30 June 2011 生效时间: 2011年6月30日 . . Principle 总则 This annex applies to all forms of compute
6、rised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill certain functionalities. 此附件适用于符合 GMP生产要求的所有形式的计算机系统。计算机系统是实现 某项特定功能的软件和硬件的组合。 The application should be validated; IT infrastructure should be qualifie
7、d. 应用程序应验证, IT基础设施应有权限设置。 Where a computerised system replaces a manual operation, there should be no resultant decrease in product quality, process control or quality assurance. There should be no increase in the overall risk of the process. 用计算机系统代替手动操作应不对产品质量、过程控制和质量保证以及过程的整 体风险产生影响。 General 常规 1
8、. Risk Management 风险管理 Risk management should be applied throughout the lifecycle of the computerised system taking into account patient safety, data integrity and product quality. As part of a risk management system, decisions on the extent of validation and data integrity controls should be based
9、on a justified and documented risk assessment of the computerised system. 风险管理应贯穿整个计算机系统生命周期,以保证病人安全、 数据完整性和产品 质量。作为风险管理系统的一部分, 由计算机系统风险评估决定验证范围和数据 完整性控制。 2. Personnel 人员 There should be close cooperation between all relevant personnel such as Process Owner, System Owner, Qualified Persons and IT. A
10、ll personnel should have appropriate qualifications, level of access and defined responsibilities to carry out their assigned duties. 所有有关人员(如工艺管理员、系统管理员、质检员和IT人员)应紧密合作。这 些人员应具有相应的资格证书、使用权限和定义好的相关工作职责。 3. Suppliers and Service Providers 供应商和服务供应商 3.1 When third parties (e.g. suppliers, service provi
11、ders) are used e.g. to provide, install, configure, integrate, validate, maintain (e.g. via remote access), modify or retain a computerised system or related service or for data processing, formal agreements must exist between the manufacturer and any third parties, and these agreements should inclu
12、de clear statements of the responsibilities of the third party. IT-departments should be considered analogous. 3.1当第三方 (如供应商、服务供应商 )为计算机系统、 相关服务或数据处理提供如 供货、安装、配置、整合、验证、维护(如通过远程访问 )、修改或保持时,厂商 . . 和任何第三方之间必须有正式协议,且在协议中应当明确第三方责任。IT部门类 似。 3.2 The competence and reliability of a supplier are key factors
13、when selecting a product or service provider. The need for an audit should be based on a risk assessment. 3.2供应商的实力和可靠性是选择供应商产品或服务的关键因素,所以需要一个 以风险评估为基础的审计。 3.3 Documentation supplied with commercial off-the-shelf products should be reviewed by regulated users to check that user requirements are fulf
14、illed. 3.3商业性标准文件应通过用户审核并符合用户需求。 3.4 Quality system and audit information relating to suppliers or developers of software and implemented systems should be made available to inspectors on request. 3.4软件和应用系统开发商或供应商的质量体系和审计信息应便于核查人员查 询。 Project Phase 项目阶段 4. Validation 验证 4.1 The validation documenta
15、tion and reports should cover the relevant steps of the life cycle. Manufacturers should be able to justify their standards, protocols, acceptance criteria, procedures and records based on their risk assessment. 4.1 验证文件和报告应包含系统生命周期的相关阶段。厂商应能够证明其标准、 协议、验收标准、规程和记录都是基于其内部风险评估的。 4.2 Validation document
16、ation should include change control records (if applicable) and reports on any deviations observed during the validation process. 4.2 验证文件应包含验证过程中的变更控制记录(如适用)和偏差报告。 4.3 An up to date listing of all relevant systems and their GMP functionality (inventory) should be available. 4.3 相关系统和其 GMP 功能(详细目录)的
17、最新清单应有效。 For critical systems an up to date system description detailing the physical and logical arrangements, data flows and interfaces with other systems or processes, any hardware and software pre-requisites, and security measures should be available. 为对一个最新的关键系统进行详细的系统描述(如物理、 逻辑流程、 数据流和与 其他系统或进
18、程的接口),任何硬件和软件都是必须的,并应有安全措施。 4.4 User Requirements Specifications should describe the required functions of the computerised system and be based on documented risk assessment and GMP impact. User requirements should be traceable throughout the life-cycle. 4.4URS 应基于风险评估和 GMP 影响性文件描述计算机系统的功能需求。用户 需求应贯
19、穿整个系统生命周期。 4.5 The regulated user should take all reasonable steps, to ensure that the system has been developed in accordance with an appropriate quality management system. The supplier should be assessed appropriately. . . 4.5 管理者应采取合理措施保证系统更新与最新的质量管理系统一致,并对供应 商作出适当的评估。 4.6 For the validation of b
20、espoke or customised computerised systems there should be a process in place that ensures the formal assessment and reporting of quality and performance measures for all the life-cycle stages of the system. 4.6 为验证固化或自定义计算机系统,应对系统生命周期的每个阶段都进行验 证,以确认正式评估、质量报告和业绩评估报告。 4.7 Evidence of appropriate test
21、methods and test scenarios should be demonstrated. Particularly, system (process) parameter limits, data limits and error handling should be considered. Automated testing tools and test environments should have documented assessments for their adequacy. 4.7 应对测试方法和测试环境加以论证,特别是系统(工艺)参数范围、数据范围 和错误处理。自
22、动化测试工具和测试环境的合适性应该有书面的评估报告。 4.8 If data are transferred to another data format or system, validation should include checks that data are not altered in value and/or meaning during this migration process. . . 4.8 数据转化成其他格式或传输到其他系统时,验证内容应包括检查其数据值和 /或含义在转化或传输过程中没有被改变。 Operational Phase 运行阶段 5. Data 数据 C
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 欧盟 GMP 附录 11 计算机系统 中英文 对照
链接地址:https://www.31doc.com/p-5640266.html